Effect of radioactive iodine therapy on cytokine production in Graves' disease: transient increases in interleukin-4 (IL-4), IL-6, IL-10, and tumor necrosis factor-alpha, with longer term increases in interferon-gamma production - PubMed (original) (raw)
Effect of radioactive iodine therapy on cytokine production in Graves' disease: transient increases in interleukin-4 (IL-4), IL-6, IL-10, and tumor necrosis factor-alpha, with longer term increases in interferon-gamma production
B M Jones et al. J Clin Endocrinol Metab. 1999 Nov.
Abstract
Spontaneous and mitogen-stimulated production of interleukin-4 (IL-4), IL-6, IL-10, IL-12, interferon-gamma (IFNgamma), and tumor necrosis factor-alpha were evaluated by enzyme-linked immunospot assay of peripheral blood mononuclear cells from patients with Graves' disease immediately before and at 4, 17, and 59 days after treatment with radioactive iodine. Patients had significantly reduced IL-4 and IFNgamma production before treatment compared with healthy controls. Both cytokines were increased to normal levels by day 17 after treatment, and IFNgamma remained at normal levels on day 59, whereas IL-4 returned to subnormal levels at this time. IL-12 production was initially normal and was not significantly altered by therapy. IL-6, IL-10, and tumor necrosis factor-alpha were also normal before radiotherapy, but increased significantly on day 17, returning to pretreatment levels by day 59. Thus, radioiodine treatment induced a transient increase in both proinflammatory and antiinflammatory cytokines and a more prolonged increase in IFNgamma production, the latter representing a definite shift toward a type 1 cytokine profile.
Similar articles
- Changes in cytokine production during pregnancy in patients with Graves' disease.
Jones BM, Kwok JS, Kung AW. Jones BM, et al. Thyroid. 2000 Aug;10(8):701-7. doi: 10.1089/10507250050137798. Thyroid. 2000. PMID: 11014316 - Serum levels of the cytokines IL-1beta, IL-6 and ICAM-1 after 131I-treatment of Graves' disease and nodular goiter.
Nygaard B, Jarløv AE, Kristensen LO, Faber J. Nygaard B, et al. Horm Metab Res. 2000 Jul;32(7):283-7. doi: 10.1055/s-2007-978637. Horm Metab Res. 2000. PMID: 10965935 - Serum Th1 and Th2 profile cytokine level changes in patients with Graves' ophthalmopathy treated with corticosteroids.
Myśliwiec J, Kretowski A, Topolska J, Siewko K, Jakubczyk D, Szelachowska M, Mikita A, Kinalska I. Myśliwiec J, et al. Horm Metab Res. 2001 Dec;33(12):739-43. doi: 10.1055/s-2001-19135. Horm Metab Res. 2001. PMID: 11753760 - High-dose growth hormone does not affect proinflammatory cytokine (tumor necrosis factor-alpha, interleukin-6, and interferon-gamma) release from activated peripheral blood mononuclear cells or after minimal to moderate surgical stress.
Zarkesh-Esfahani SH, Kolstad O, Metcalfe RA, Watson PF, von Laue S, Walters S, Revhaug A, Weetman AP, Ross RJ. Zarkesh-Esfahani SH, et al. J Clin Endocrinol Metab. 2000 Sep;85(9):3383-90. doi: 10.1210/jcem.85.9.6823. J Clin Endocrinol Metab. 2000. PMID: 10999838 Clinical Trial.
Cited by
- The influencer effect of Dexmedetomidine on radioiodine relevant to lacrimal gland impairment.
Şingar E, Akbulut A, Koca G, Yazihan N, Atilgan Hİ, Yumuşak N, Demir A, Burcu A, Korkmaz M. Şingar E, et al. Int Ophthalmol. 2024 Feb 27;44(1):115. doi: 10.1007/s10792-024-03052-6. Int Ophthalmol. 2024. PMID: 38411703 - Wound fluids collected postoperatively from patients with breast cancer induce epithelial to mesenchymal transition but intraoperative radiotherapy impairs this effect by activating the radiation-induced bystander effect.
Kulcenty K, Piotrowski I, Zaleska K, Wichtowski M, Wróblewska J, Murawa D, Suchorska WM. Kulcenty K, et al. Sci Rep. 2019 May 27;9(1):7891. doi: 10.1038/s41598-019-44412-y. Sci Rep. 2019. PMID: 31133667 Free PMC article. - Impaired immune regulation after radioiodine therapy for Graves' disease and the protective effect of Methimazole.
Côté-Bigras S, Tran V, Turcotte S, Rola-Pleszczynski M, Verreault J, Rottembourg D. Côté-Bigras S, et al. Endocrine. 2016 Jun;52(3):587-96. doi: 10.1007/s12020-015-0832-2. Epub 2015 Dec 23. Endocrine. 2016. PMID: 26701678 - Cytokine production in peripheral blood cells of patients with differentiated thyroid cancer: elevated Th2/Th9 cytokine production before and reduced Th2 cytokine production after radioactive iodine therapy.
Simonovic SZ, Mihaljevic O, Majstorovic I, Djurdjevic P, Kostic I, Djordjevic OM, Teodorovic LM. Simonovic SZ, et al. Cancer Immunol Immunother. 2015 Jan;64(1):75-82. doi: 10.1007/s00262-014-1619-7. Epub 2014 Oct 9. Cancer Immunol Immunother. 2015. PMID: 25297452 Free PMC article. - Thyroglobulin autoantibodies switch to immunoglobulin (Ig)G1 and IgG3 subclasses and preserve their restricted epitope pattern after 131I treatment for Graves' hyperthyroidism: the activity of autoimmune disease influences subclass distribution but not epitope pattern of autoantibodies.
Latrofa F, Ricci D, Montanelli L, Piaggi P, Mazzi B, Bianchi F, Brozzi F, Santini P, Fiore E, Marinò M, Tonacchera M, Vitti P. Latrofa F, et al. Clin Exp Immunol. 2014 Dec;178(3):438-46. doi: 10.1111/cei.12438. Clin Exp Immunol. 2014. PMID: 25134846 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources